Treatment of psoriatic arthritis with etanercept, a tumour necrosis factor antagonist

Author： Wong Vicky Kwan   Lebwohl Mark G  

Publisher： Informa Healthcare

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.5, Iss.11, 2005-11, pp. : 1505-1513

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Etanercept in psoriatic arthritis

By Anandarajah Allen P   Ritchlin Christopher T  

Expert Opinion on Biological Therapy, Vol. 3, Iss. 1, 2003-02 ,pp. : 169-177

Informa Healthcare

Access to resources Recommend Favorite

Etanercept in the treatment of rheumatoid arthritis

By Hunt Laura   Emery Paul  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 10, 2013-10 ,pp. : 1441-1450

Informa Healthcare

Access to resources Recommend Favorite

Etanercept (Enbrel) in the treatment of juvenile idiopathic arthritis

By Berard Roberta A   Laxer Ronald M  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 11, 2013-11 ,pp. : 1623-1630

Informa Healthcare

Access to resources Recommend Favorite

Adalimumab for the treatment of severe psoriasis and psoriatic arthritis

By Papoutsaki Marina   Costanzo Antonio   Chimenti Maria-Sole   Chimenti Sergio  

Expert Opinion on Biological Therapy, Vol. 8, Iss. 3, 2008-03 ,pp. : 363-370

Informa Healthcare

Access to resources Recommend Favorite

Anti-TNF-α agents in the treatment of psoriatic arthritis

By Brandt Jan   Braun Jürgen  

Expert Opinion on Biological Therapy, Vol. 6, Iss. 2, 2006-02 ,pp. : 99-107

Informa Healthcare

Access to resources Recommend Favorite